Market Tracker

09/22 6:05pm ET

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

During the Trading Day
12.99 -0.49 / -3.64%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
12.60 -0.39 / -3.00%
 
Volume: 13.7K

Today’s Trading

Previous close13.48
Today’s open13.50
Day’s range12.81 - 13.64
Volume2,620,655
Average volume (3 months)2,385,103
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 09/22/2014

Growth & Valuation

Earnings growth (last year)-63.84%
Earnings growth (this year)-53.29%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales149.87
Price/Book24.54

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...-0.15-2.60%
DYAXDyax Corp+0.01+0.10%
NKTRNektar Therapeutics-0.29-2.26%
NXTMNxStage Medical Inc-0.09-0.67%
Data as of 3:59pm ET, 09/22/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$7.0M
Annual profit (last year)-$46.7M
Net profit margin-667.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
Chief Operating Officer &
Executive Vice President
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts